Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Pilot Investigation Of The Relationship Of Short Term Depo-Provera (Medroxyprogesterone Acetate) Exposure To The Morphologic , Biochemical, And Molecular Changes In Primary Endometroid Adenocarcinoma of the Uterine Corpus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00064025
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:14.884471+00:00
Published At
2014-08-15T00:00:00+00:00
Record Updated At
2016-04-11
Results Posted At
2014-08-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Endometrial Adenocarcinoma", "Endometrial Adenosquamous Carcinoma", "Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation", "Recurrent Uterine Corpus Carcinoma", "Stage I Uterine Corpus Cancer", "Stage II Uterine Corpus Cancer", "Stage III Uterine Corpus Cancer", "Stage IV Uterine Corpus Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-04-11"
protocolSection.identificationModule.nctId
"NCT00064025"
protocolSection.identificationModule.officialTitle
"A Phase II Pilot Investigation Of The Relationship Of Short Term Depo-Provera (Medroxyprogesterone Acetate) Exposure To The Morphologic , Biochemical, And Molecular Changes In Primary Endometroid Adenocarcinoma of the Uterine Corpus"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-08-15"

Study condition terms

  • Endometrial Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation (protocolSection.conditionsModule.conditions)
  • Recurrent Uterine Corpus Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.